1. Home
  2. CTKB vs VALU Comparison

CTKB vs VALU Comparison

Compare CTKB & VALU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTKB
  • VALU
  • Stock Information
  • Founded
  • CTKB 1990
  • VALU 1931
  • Country
  • CTKB United States
  • VALU United States
  • Employees
  • CTKB N/A
  • VALU N/A
  • Industry
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • VALU Investment Managers
  • Sector
  • CTKB Health Care
  • VALU Finance
  • Exchange
  • CTKB Nasdaq
  • VALU Nasdaq
  • Market Cap
  • CTKB 433.8M
  • VALU 365.4M
  • IPO Year
  • CTKB 2021
  • VALU N/A
  • Fundamental
  • Price
  • CTKB $4.01
  • VALU $37.07
  • Analyst Decision
  • CTKB Hold
  • VALU
  • Analyst Count
  • CTKB 4
  • VALU 0
  • Target Price
  • CTKB $6.00
  • VALU N/A
  • AVG Volume (30 Days)
  • CTKB 691.9K
  • VALU 4.6K
  • Earning Date
  • CTKB 11-05-2025
  • VALU 12-12-2025
  • Dividend Yield
  • CTKB N/A
  • VALU 3.51%
  • EPS Growth
  • CTKB N/A
  • VALU 6.17
  • EPS
  • CTKB N/A
  • VALU 2.26
  • Revenue
  • CTKB $196,035,000.00
  • VALU $34,801,000.00
  • Revenue This Year
  • CTKB N/A
  • VALU N/A
  • Revenue Next Year
  • CTKB $7.25
  • VALU N/A
  • P/E Ratio
  • CTKB N/A
  • VALU $17.20
  • Revenue Growth
  • CTKB N/A
  • VALU N/A
  • 52 Week Low
  • CTKB $2.37
  • VALU $32.94
  • 52 Week High
  • CTKB $7.63
  • VALU $57.68
  • Technical
  • Relative Strength Index (RSI)
  • CTKB 51.16
  • VALU 41.29
  • Support Level
  • CTKB $4.00
  • VALU $38.14
  • Resistance Level
  • CTKB $4.42
  • VALU $40.00
  • Average True Range (ATR)
  • CTKB 0.20
  • VALU 0.82
  • MACD
  • CTKB 0.01
  • VALU -0.18
  • Stochastic Oscillator
  • CTKB 38.81
  • VALU 2.24

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

About VALU Value Line Inc.

Value Line Inc is a U.S based company. It produces investment periodicals based on underlying research and making available copyright data, including ranking system and other information, to third parties under written agreements for use in third-party managed and marketed investment products and for other purposes. The company markets under brands including Value Line, the Value Line logo, The Value Line Investment Survey, Smart Research, Smarter Investing and a trusted name in Investment Research. Its only operating segment being Publishing.

Share on Social Networks: